bosentan anhydrous has been researched along with Dilatation, Pathologic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bejjani, G; Biarent, D; Hubloue, I; Jespers, P; Leeman, M; Mélot, C; Naeije, R | 1 |
Almeida, AR; Almeida, S; Carrageta, M; Cordeiro, P; Cotrim, C; Loureiro, MJ; Miranda, R; Simões, O | 1 |
2 other study(ies) available for bosentan anhydrous and Dilatation, Pathologic
Article | Year |
---|---|
Role of endothelins and nitric oxide in the pulmonary circulation of perinatal lambs during hyperoxia and hypoxia.
Topics: Animals; Animals, Newborn; Blood Pressure; Bosentan; Constriction, Pathologic; Dilatation, Pathologic; Endothelin Receptor Antagonists; Endothelins; Hyperoxia; Hypoxia; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Pulmonary Artery; Pulmonary Circulation; Sheep, Domestic; Sulfonamides; Vascular Resistance | 2006 |
Should right ventricle dilatation during exercise have clinical implications in patients with chronic thromboembolic pulmonary hypertension? Case report.
Topics: Adult; Antihypertensive Agents; Bosentan; Cardiac Catheterization; Dilatation, Pathologic; Echocardiography, Doppler; Exercise Test; Female; Humans; Hypertension, Pulmonary; Piperazines; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Thromboembolism; Vascular Resistance; Vasodilator Agents; Ventricular Dysfunction, Right | 2007 |